CTLA4 and cancer: In contrast, our previous study involving human Ctla4 knock-in mice showed that the levels of anti-DNA antibodies and cancer rejection parameters do not always correlate with each other.24 In particular, we found that one of the antibodies tested, L3D10, conferred strongest CITE but yet induced the lowest levels of anti-DNA antibodies among several mAbs tested.